Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials-Reference-Cited by-同舟云学术

Regional citrate versus heparin anticoagulation for continuous renal replacement therapy in critically ill patients: a meta-analysis with trial sequential analysis of randomized controlled trials

Published:2016-05-13 Issue:1 Volume:20 Page:
ISSN:1364-8535
Container-title:Critical Care
language:en
Short-container-title:Crit Care

Author:

Liu Chao,Mao Zhi,Kang Hongjun,Hu Jie,Zhou Feihu

Publisher

Springer Science and Business Media LLC

Subject

Critical Care and Intensive Care Medicine

Link

http://link.springer.com/content/pdf/10.1186/s13054-016-1299-0

Reference44 articles.

1. Joannidis M, Oudemans-van Straaten HM. Clinical review: Patency of the circuit in continuous renal replacement therapy. Crit Care. 2007;11(4):218.

2. Davenport A. What are the anticoagulation options for intermittent hemodialysis? Nat Rev Nephrol. 2011;7(9):499–508.

3. Oudemans-van Straaten HM, Kellum JA, Bellomo R. Clinical review: anticoagulation for continuous renal replacement therapy–heparin or citrate? Crit Care. 2011;15(1):202.

4. Pinnick RV, Wiegmann TB, Diederich DA. Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med. 1983;308(5):258–61.

5. Section 5: Dialysis Interventions for Treatment of AKI. Kidney Int Suppl (2011). 2012;2(1):89–115. PMID:25018921 [PubMed] PMCID:PMC4089702. http://dx.doi.org/10.1038/kisup.2011.35

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Regional citrate anticoagulation versus LMWH anticoagulation for CRRT in liver failure patients without increased bleeding risk;The International Journal of Artificial Organs;2024-08-24

2. A safe and effective protocol for postdilution hemofiltration with regional citrate anticoagulation;BMC Nephrology;2024-07-09

3. Early experience of using regional citrate anticoagulation for continuous renal replacement therapy in critically ill patients in a resource‐limited setting;Nephrology;2024-06-03

4. Citrate anticoagulation and systemic heparin anticoagulation during continuous renal replacement therapy among critically-ill children;Pediatric Research;2024-03-30

5. Kidney replacement and conservative therapies in rhabdomyolysis: a retrospective analysis;BMC Nephrology;2024-03-14